Mark Collison, Heart & Stroke Foundation - Visions for Pharmacare


Published on

  • Be the first to comment

  • Be the first to like this

Mark Collison, Heart & Stroke Foundation - Visions for Pharmacare

  1. 1. Pharmacare 2020Visions for Pharmacare Panel“Patient Perspective”Mark CollisonDirector, AdvocacyHeart and Stroke Foundation|BC & Yukon
  2. 2. Some Facts / Some Challenges Roughly half of Canadian adults take at least one prescription medication, while 15% take four or more Over 40% of Canadian seniors and 37% of people with chronic disease take four or more prescription medications In 2010 Canadian pharmacies dispensed roughly 77,000,000 prescriptions for medications to treat cardiovascular disease Roughly 3.5 million Canadians are either under insured (2.5 million) or not insured at all (1 million) 12% (4.1 million) Canadians reported paying more than $1,000 per year in out-of pocket costs 10% (3.4 million) Canadians either did not fill a prescription or skipped doses as a result of cost of medication
  3. 3. A Proposed Vision for National Pharmacare The Heart and Stroke Foundation believes that all Canadians should have access to prescription drug coverage that is timely, affordable, flexible and focused on achieving the most favourable health outcomes possible. Such a system of coverage must also strive to be sustainable over the long-term and work to provide Canadians with optimal value and benefits for the health care investments made. These two things need not be mutually exclusive and while difficult to balance, are in fact achievable.
  4. 4. Primary Goals Required to Achieve Vision
  5. 5. Goal #1 - Coverage Attributes of Coverage Equitable coverage – no one should be without some form of coverage for prescription medications Catastrophic coverage – no one should face extraordinary costs for prescription medications Access Standards - reasonable and timely access to quality prescription medications Payer Network - combination of payers - private, public and patient – the order and weighting of payers will depend on an individual’s specific circumstance
  6. 6. Goal #2 - Choice Attributes of Choice Accommodating – tailored to the needs of the individual, not a “one size fits all” approach Autonomous - maintaining the independence and integrity of the patient-prescriber-pharmacist relationship Variety – must provide for a range of medication options in order to provide the most effective treatment Flexible – efficient system to allow patients to easily move or graduate to other drugs within and between classes
  7. 7. Goal # 3 - Capacity Attributes of Capacity Best Practice/Evidence – systems and processes that enable and support prescribers and pharmacists to make most efficient and effective decisions (appropriate prescribing) Self Efficacy/Empowerment – systems and processes that enable and support patients to understand their medication, treatment goals and regimens and self-manage (appropriate use) Quality Assurance – systems and processes that provide for a high level of vigilance in terms of drug quality and safety, optimal prescribing and outcomes, and incorporate the most current research and best practice (system competence)
  8. 8. Goal #4 - Quality Attributes of Quality Accountable – on the part of all parties – patients, prescribers, pharmacists, manufacturers, payers, policy-makers, politicians Reasonable – finding the right balance between open, closed & restricted access, cost-effectiveness and quality outcomes, brand and generic, research & innovation and economic & societal benefits Affordable – if we come to terms with the above two attributes will we be there? Or are we still just searching for the holy grail? Sustainable – finding the equilibrium that will produce and sustain a quality national Pharmacare system that will be resilient to the demands of current and future generations
  9. 9. Thank you!